Blackstone to invest $400 million in gene therapy venture with Ferring

Blackstone Group Inc said on Monday it will invest $400 million in a joint venture with Swiss drug company Ferring that is working on an experimental gene therapy for bladder cancer, the private equity giant's largest ever bet on drug development.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news